226 related articles for article (PubMed ID: 21796761)
1. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.
von Hoff K; Hinkes B; Dannenmann-Stern E; von Bueren AO; Warmuth-Metz M; Soerensen N; Emser A; Zwiener I; Schlegel PG; Kuehl J; Frühwald MC; Kortmann RD; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2011 Dec; 57(6):978-85. PubMed ID: 21796761
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
3. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
4. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.
Hilden JM; Meerbaum S; Burger P; Finlay J; Janss A; Scheithauer BW; Walter AW; Rorke LB; Biegel JA
J Clin Oncol; 2004 Jul; 22(14):2877-84. PubMed ID: 15254056
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.
Lafay-Cousin L; Hawkins C; Carret AS; Johnston D; Zelcer S; Wilson B; Jabado N; Scheinemann K; Eisenstat D; Fryer C; Fleming A; Mpofu C; Larouche V; Strother D; Bouffet E; Huang A
Eur J Cancer; 2012 Feb; 48(3):353-9. PubMed ID: 22023887
[TBL] [Abstract][Full Text] [Related]
7. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
[TBL] [Abstract][Full Text] [Related]
8. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis.
Buscariollo DL; Park HS; Roberts KB; Yu JB
Cancer; 2012 Sep; 118(17):4212-9. PubMed ID: 22213196
[TBL] [Abstract][Full Text] [Related]
10. Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany.
Reinhard H; Reinert J; Beier R; Furtwängler R; Alkasser M; Rutkowski S; Frühwald M; Koscielniak E; Leuschner I; Kaatsch P; Graf N
Oncol Rep; 2008 Mar; 19(3):819-23. PubMed ID: 18288421
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system tumors in chinese children under the age of 3: a population study.
Liu AP; Shing MM; Yuen HL; Li CH; Ling SC; Luk CW; Ha SY; Li CK; Chan GC
J Pediatr Hematol Oncol; 2015 Mar; 37(2):94-103. PubMed ID: 24608077
[TBL] [Abstract][Full Text] [Related]
12. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
Athale UH; Duckworth J; Odame I; Barr R
J Pediatr Hematol Oncol; 2009 Sep; 31(9):651-63. PubMed ID: 19707161
[TBL] [Abstract][Full Text] [Related]
13. Atypical teratoid/rhabdoid tumors of the central nervous system: management and outcomes.
Chen ML; McComb JG; Krieger MD
Neurosurg Focus; 2005 Jun; 18(6A):E8. PubMed ID: 16048294
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
[TBL] [Abstract][Full Text] [Related]
15. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Meisner C; Pietsch T; Deinlein F; Urban C; Warmuth-Metz M; Bamberg M
J Clin Oncol; 2006 Apr; 24(10):1554-60. PubMed ID: 16575007
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
Fischer-Valuck BW; Chen I; Srivastava AJ; Floberg JM; Rao YJ; King AA; Shinohara ET; Perkins SM
Cancer; 2017 Feb; 123(4):682-687. PubMed ID: 27861763
[TBL] [Abstract][Full Text] [Related]
17. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors.
Sultan I; Qaddoumi I; Rodríguez-Galindo C; Nassan AA; Ghandour K; Al-Hussaini M
Pediatr Blood Cancer; 2010 Jan; 54(1):35-40. PubMed ID: 19798737
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
19. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
20. Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges.
Strother D
Expert Rev Anticancer Ther; 2005 Oct; 5(5):907-15. PubMed ID: 16221059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
